Pharmacological Co-Activation of TrkB and TrkC Receptor Signaling Ameliorates Striatal Neuropathology and Motor Deficits in Mouse Models of Huntington’s Disease
Danielle A. Simmons(Cornell University), Frank M. Longo(Stanford University)
Cited by 11
Related Papers
The p75 Neurotrophin Receptor Promotes Amyloid-β(1-42)-Induced Neuritic Dystrophy<i>In Vitro</i>and<i>In Vivo</i>
|Journal of Neuroscience|2009|190
Small, Nonpeptide p75<sup>NTR</sup>Ligands Induce Survival Signaling and Inhibit proNGF-Induced Death
|Journal of Neuroscience|2006|178
A Small Molecule TrkB Ligand Reduces Motor Impairment and Neuropathology in R6/2 and BACHD Mouse Models of Huntington's Disease
|Journal of Neuroscience|2013|147
Small molecule modulation of the p75 neurotrophin receptor inhibits multiple amyloid beta-induced tau pathologies
|Scientific Reports|2020|38
PAK1 inhibitor NVS‐PAK1‐1 preserves dendritic spines in amyloid/tau exposed neurons and 5xFAD mice
|Alzheimer s & Dementia|2025|0